Log in to save to my catalogue

Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucin...

Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_546ba8af962b49deaa4afd35f88e5578

Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms

About this item

Full title

Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms

Publisher

Germany: BioMed Central Ltd

Journal title

Clinical epigenetics, 2023-02, Vol.15 (1), p.28-28, Article 28

Language

English

Formats

Publication information

Publisher

Germany: BioMed Central Ltd

More information

Scope and Contents

Contents

Intraductal papillary mucinous neoplasms (IPMNs), a type of cystic pancreatic cancer (PC) precursors, are increasingly identified on cross-sectional imaging and present a significant diagnostic challenge. While surgical resection of IPMN-related advanced neoplasia, i.e., IPMN-related high-grade dysplasia or PC, is an essential early PC detection st...

Alternative Titles

Full title

Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_546ba8af962b49deaa4afd35f88e5578

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_546ba8af962b49deaa4afd35f88e5578

Other Identifiers

ISSN

1868-7083,1868-7075

E-ISSN

1868-7083,1868-7075

DOI

10.1186/s13148-023-01429-5

How to access this item